NDC 0641-6002-01 - Ativan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6002
- Requested NDC
- 0641-6002-01
- Package NDCs from labels
- 0641-6002-01, 0641-6002-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2026-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATIVAN Injection (lorazepam injection, USP) | Hikma Pharmaceuticals USA Inc. | 2026-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6002-01 | Ativan | 10 mL in 1 VIAL | INJECTION | 10 | 12 | |
| 0641-6002-10 | Ativan | 10 in 1 CARTON | INJECTION | 10 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6002-01 | ML - Milliliter | 0641-6002 | f51a57a8-324c-4d08-a3bb-68f6e744e263 | 1 | 2012-07-24 |
| 0641-6002-10 | ML - Milliliter | 0641-6002 | 654d1181-2ea8-46cf-a1fa-5a7dbf11c314 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ATIVAN (LORAZEPAM) INJECTION ATIVAN (LORAZEAPM) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Asclemed USA, Inc. | ebdf72f7-7462-4b83-81b4-c7988860c728 | 2024-11-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | 9aa060f1-f8f6-46e6-a7d0-bd46a73f2676 | 2024-10-17 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8fa33078-c379-41f5-e053-2995a90acced | 2024-10-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dc1-3746-e054-00144ff8d46c | 2024-10-08 | Warnings, Adverse reactions | O26FZP769L |
| Fast Freeze Lidocaine Roll-On | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | Natural Essentials, Inc. | 74b06366-5eb4-4eba-aa2b-2b672828294d | 2024-10-04 | Warnings | LKG8494WBH |
| CVS Health Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | NATURAL ESSENTIALS, INC. | 1adb9b74-4a01-4461-b845-f3aedcb3f810 | 2024-10-01 | Warnings | LKG8494WBH |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 6DC9Q167V3 |
| blink tears | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 10fcf407-6eaf-4730-9ed0-9b7715cf5701 | 2024-09-20 | Warnings | B697894SGQ |
| blink gel tears | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | 6f7e06c3-204d-459a-af8f-c46be9ad0e8d | 2024-09-20 | Warnings | B697894SGQ |
| Soothe | GLYCERIN AND PROPYLENE GLYCOL | Bausch & Lomb Incorporated | fef002ea-c4bd-4486-a42e-1bbd9d73d28d | 2024-09-20 | Warnings | 6DC9Q167V3 |
| Leader Preservative-Free Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | 2a2aa620-ca63-4698-88fd-fc263b8fa0d1 | 2024-09-07 | Warnings | 6DC9Q167V3 B697894SGQ |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 853c762d-0772-4f02-99ca-0bc2911f09f0 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4ab77192-8fe9-2965-e054-00144ff88e88 | 2024-07-19 | Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | a4fe8df0-3ce8-b8b8-e053-2995a90a28f4 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Ivarest | ZINC OXIDE, BENZYL ALCOHOL, AND DIPHENHYDRAMINE HYDROCHLORIDE | Blistex Inc | 6f68cbbb-6269-4bb3-8cc9-50b146703b42 | 2024-07-09 | Warnings | LKG8494WBH |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 50379c41-2676-590c-e054-00144ff8d46c | 2024-07-08 | Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1bcf608a-11c1-ec7d-e063-6394a90ab710 | 2024-06-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8aace309-f3ef-6aef-e053-2995a90aa197 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 933b5ef3-ec29-1a96-e053-2995a90a2d33 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | aac672f9-0ba7-4852-b8a7-caac9e4b1e77 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.